SCHEMBL29616293

SCHEMBL29616293

C[C@@H]1CN(C(=O)N2CC[C@@H]3OCC(=O)N[C@@H]3C2)CCC1c1ccc(C(C)(F)F)cn1

nearest known ligand 0.51

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
MGLL Q99685 10/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23148891 1.00 MGLL (0.51) MGLL
SCHEMBL23148883 1.00 MGLL (0.51) MGLL
SCHEMBL21390420 1.00 MGLL (0.51) MGLL
SCHEMBL21390304 1.00 MGLL (0.51) MGLL
SCHEMBL23148935 1.00 MGLL (0.51) MGLL
SCHEMBL23149192 0.90 MGLL (0.56) MGLL
SCHEMBL21390296 0.90 MGLL (0.56) MGLL
SCHEMBL23149194 0.90 MGLL (0.56) MGLL
SCHEMBL23211966 0.82 MGLL (0.61) MGLL
SCHEMBL23211965 0.82 MGLL (0.61) MGLL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4034538-A1 NEW HETEROCYCLIC MONOACYLGLYCEROL LIPASE (MAGL) INHIBITORS F. Hoffmann-La Roche AG (CH) 2022-08-03 EP claimed
CN-114401968-A Novel heterocyclic monoacylglycerol lipase (MAGL) inhibitors 豪夫迈·罗氏有限公司 2022-04-26 CN claimed
EP-4034538-A1 NEW HETEROCYCLIC MONOACYLGLYCEROL LIPASE (MAGL) INHIBITORS F. Hoffmann-La Roche AG (CH) 2022-08-03 EP disclosed
CN-114401968-A Novel heterocyclic monoacylglycerol lipase (MAGL) inhibitors 豪夫迈·罗氏有限公司 2022-04-26 CN disclosed